Amiodarone and thyroid autoimmunity in the United Kingdom.
作者信息
Weetman A P, Bhandal S K, Burrin J M, Robinson K, McKenna W
机构信息
Department of Medicine, Royal Postgraduate Medical School, London.
出版信息
BMJ. 1988 Jul 2;297(6640):33. doi: 10.1136/bmj.297.6640.33.
Abstract
摘要
相似文献
1
Amiodarone and thyroid autoimmunity in the United Kingdom.英国的胺碘酮与甲状腺自身免疫
BMJ. 1988 Jul 2;297(6640):33. doi: 10.1136/bmj.297.6640.33.
2
Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.抗甲状腺抗体作为胺碘酮所致甲状腺疾病的早期标志物。
Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):227-8. doi: 10.1136/bmj.292.6515.227.
3
Long-term amiodarone therapy and antithyroid antibodies.长期胺碘酮治疗与抗甲状腺抗体
Am J Cardiol. 1992 Apr 1;69(9):971-2. doi: 10.1016/0002-9149(92)90805-9.
4
Amiodarone and antithyroid antibodies.胺碘酮与抗甲状腺抗体。
Ann Intern Med. 1985 Jul;103(1):157-8. doi: 10.7326/0003-4819-103-1-157_2.
5
Effect of amiodarone on circulating antithyroid antibodies.胺碘酮对循环抗甲状腺抗体的影响。
BMJ. 1988 Aug 13;297(6646):456-7. doi: 10.1136/bmj.297.6646.456.
6
[Thyroid function in patients during long-term treatment with amiodarone].[胺碘酮长期治疗患者的甲状腺功能]
Endokrynol Pol. 1992;43(1):39-46.
7
[Autoimmunity in thyroid disease secondary to amiodarone: heredofamilial aspects].[胺碘酮所致甲状腺疾病中的自身免疫：遗传家族性因素]
Arch Inst Cardiol Mex. 1988 May-Jun;58(3):197-202.
8
Effect of amiodarone on thyroid hormone economy.胺碘酮对甲状腺激素代谢的影响。
Isr J Med Sci. 1984 Feb;20(2):113-7.
9
[Dysthyroidism caused by amiodarone. Frequency and diagnosis].[胺碘酮所致甲状腺功能异常。发生率及诊断]
Arch Mal Coeur Vaiss. 1989 Oct;82(10):1747-50.
10
[Thyroid dysfunctions related to amiodarone. Prospective survey with 116 patients].[与胺碘酮相关的甲状腺功能障碍。对116例患者的前瞻性调查]
Rev Med Interne. 1993;14(10):955. doi: 10.1016/s0248-8663(05)80073-6.
引用本文的文献
1
The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis-Review.环境因素对自身免疫性甲状腺炎发展的影响——综述
Biomedicines. 2024 Aug 7;12(8):1788. doi: 10.3390/biomedicines12081788.
2
AMIODARONE AND THYROID DYSFUNCTION.胺碘酮与甲状腺功能异常。
Acta Clin Croat. 2022 Aug;61(2):327-341. doi: 10.20471/acc.2022.61.02.20.
3
Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.胺碘酮所致甲状腺毒症和甲状腺功能减退的发生率及可预测性。
Wien Klin Wochenschr. 2008;120(15-16):493-8. doi: 10.1007/s00508-008-1017-2.
4
Risk-benefit assessment of amiodarone in the treatment of cardiac arrhythmias.胺碘酮治疗心律失常的风险效益评估。
Drug Saf. 1990 Jul-Aug;5(4):286-304. doi: 10.2165/00002018-199005040-00005.
本文引用的文献
1
Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies.单克隆和血清微粒体自身抗体的酶联免疫测定
Clin Chim Acta. 1984 Apr 27;138(3):237-44. doi: 10.1016/0009-8981(84)90130-x.
2
Pathology of the thyroid in amiodarone-associated thyrotoxicosis.胺碘酮相关性甲状腺毒症的甲状腺病理学
Am J Surg Pathol. 1987 Mar;11(3):197-204. doi: 10.1097/00000478-198703000-00004.
3
Amiodarone and thyroid hormone metabolism.胺碘酮与甲状腺激素代谢
Postgrad Med J. 1986 Oct;62(732):909-14. doi: 10.1136/pgmj.62.732.909.
4
Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.抗甲状腺抗体作为胺碘酮所致甲状腺疾病的早期标志物。
Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):227-8. doi: 10.1136/bmj.292.6515.227.
Zotero 插件